Qatar pharmacists’ understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care

International Journal of Clinical Pharmacy

Volumn 38, Issue 2, 2016, Pages 330-343

  El Hajj, Maguy Saffouh ^a   AL Saeed, Hassna Sohil ^b   Khaja, Maryam ^c  

^a Qatar University ^*  (Qatar)

^b HAMAD MEDICAL CORPORATION   (Qatar)

^c SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

Author keywords

Pharmaceutical care; Pharmacist; Qatar

Indexed keywords

ACCESS TO INFORMATION; ADULT; ARTICLE; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; DOCTOR PATIENT RELATION; FEMALE; HUMAN; MALE; MEDICAL DOCUMENTATION; MEDICAL INFORMATION; MEDICATION COMPLIANCE; PATIENT CARE; PATIENT INFORMATION; PATIENT MONITORING; PERSONNEL SHORTAGE; PHARMACEUTICAL CARE; PHARMACIST ATTITUDE; PRIORITY JOURNAL; QATAR; SKILL; TIME; WORK EXPERIENCE; COMPREHENSION; HEALTH PERSONNEL ATTITUDE; PERCEPTION; PHARMACIST; PHARMACY; PROFESSIONAL STANDARD; PSYCHOLOGY;

ADULT; ATTITUDE OF HEALTH PERSONNEL; COMPREHENSION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; PERCEPTION; PHARMACEUTICAL SERVICES; PHARMACISTS; PROFESSIONAL ROLE; QATAR;

EID: 84954349647     PISSN: 22107703     EISSN: 22107711     Source Type: Journal    
DOI: 10.1007/s11096-016-0246-0     Document Type: Article

References (34)

1. Cipolle R, Strand L, Morley P. Pharmaceutical care practice: the patient-centered approach to medication management. McGraw-Hill Medical; 2012. (ISBN-13: 978-0071756389).
2. Odedina FT, Segal R. Behavioral pharmaceutical care scale for measuring pharmacist’s activities. Am J Health Syst Pharm. 1996;53:855–65.
3. Ernst F, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc. 2001;41(2):192–9.
4. Davies EC, Green CF, Taylor S, Williamson PR, Mottram DR, Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS One. 2009;4(2):e4439.
5. Westerlund T, Marklund B. Assessment of the clinical and economic outcomes of pharmacy interventions in drug related problems. J Clin Pharm Ther. 2009;34:319–27.
6. Beney J, Bero LA, Bond C. Expanding the roles of outpatient pharmacists: effects on health services utilization, costs, and patient outcomes. Cochrane Database Syst Rev. 2000;3:CD000336.
7. Jokanovic N, Tan EC, van den Bosch D, Kirkpatrick CM, Dooley MJ, Bell JS. Clinical medication review in Australia: a systematic review. Res Social Adm Pharm. 2015. http://dx.doi.org/10.1016/j.sapharm.2015.06.007.
8. Tan EC, Stewart K, Elliott RA, George J. Pharmacist services provided in general practice clinics: a systematic review and meta-analysis. Res Social Adm Pharm. 2014;10(4):608–22.
9. International Pharmaceutical Federation. FIP statement of professional standards pharmaceutical care, 1998.
10. American Society of Health System Pharmacy. ASHP Statement on Pharmaceutical Care, 1993. [cited 1 July 2014]. Available at: http://www.ashp.org/DocLibrary/BestPractices/OrgStPharmCare.aspx.
11. Christensen DB, Farris KB. Pharmaceutical care in community pharmacies: practice and research in the US. Ann Pharmacother. 2006;40:1400–6.
12. Hughes CM, Hawwa AF, Scullin C, Anderson C, Bernsten CB, Bjornsdottir I, et al. Provision of pharmaceutical care by community pharmacists: a comparison across Europe. Pharm World Sci. 2010;32:472–87.
13. Ngorsuraches S, Li SC. Thai pharmacists’ understanding, attitudes, and perceived barriers related to providing pharmaceutical care. Am J Health Syst Pharm. 2006;63(21):144–50.
14. Jones EJ, Mackinnon NJ, Tsuyuki RT. Pharmaceutical care in community pharmacies: practice and research in Canada. Ann Pharmacother. 2005;39(9):1527–33.
15. Dunlop JA, Shaw JP. Community pharmacists’ perspectives on pharmaceutical care implementation in New Zealand. Pharm World Sci. 2002;24(6):224–30.
16. Wibowo Y, Berbatis C, Joyce A, Sunderland VB. Analysis of enhanced pharmacy services in rural community pharmacies in Western Australia. Rural Remote Health. 2010;10(3):1400.
17. Fang Y, Yang S, Feng B, Ni Y, Zhang K. Pharmacists’ perception of pharmaceutical care in community pharmacy: a questionnaire survey in Northwest China. Health Soc Care Community. 2011;19(2):189–97.
18. Aburuz S, Al-Ghazawi M, Snyder A. Pharmaceutical care in a community-based practice setting in Jordan: where are we now with our attitudes and perceived barriers? Int J Pharm Pract. 2012;20(2):71–9.
19. The World Factbook, Qatar, 2015. [cited 13 Oct 2015]. https://www.cia.gov/library/publications/the-world-factbook/geos/qa.html.
20. Hamad Medical Corporation. Annual Health Report, 2012. [cited 1 July 2014]. http://site.hmc.org.qa/msrc/AHR2012/2012.html.
21. Qatar Supreme Council of Health. National Health Strategy 2011- 2016, 2014. [cited 1 July 2014]. http://www.nhsq.info/.
22. Rossing C, Hansen EH, Krass I. The provision of pharmaceutical care in Denmark: a cross-sectional survey. J Clin Pharm Ther. 2003;28:311–8.
23. Ramaswamy-Krishnarajan J, Hill DS. Pharmaceutical care in Canada: an exploratory study of 81 community pharmacies. Can Pharm J/Revue des Pharmaciens du Canada. 2005;138:46–50.
24. El Hajj M, Kheir N, Zaidan M, Jewesson P. Pharmacist characteristics, medication use perceptions, and professional satisfaction: a first national survey in the state of Qatar. J Healthc Leadersh. 2011;3:9–28.
25. Roughead L, Semple S, Vitry AI. Pharmaceutical care services: a systematic review of published studies, 1990–2003, examining effectiveness to improve patient outcomes. Int J Pharm Pract. 2005;13:53–70.
26. El Hajj MS, Hamid Y. Breast cancer health promotion in Qatar: a survey of community pharmacists’ interests and needs. Int J Clin Pharm. 2011;33(1):70–9.
27. El Hajj MS, Al Nakeeb RR, Al-Qudah RA. Smoking cessation counseling in Qatar: community pharmacists’ attitudes, role perceptions and practices. Int J Clin Pharm. 2012;34(4):667–76.
28. Hepler CD. Clinical pharmacy, pharmaceutical care, and the quality of drug therapy. Pharmacotherapy. 2004;24(11):1491–8.
29. Arifi MN, Al-Dhuwaili AA, Gubara OA, Al-Omar HA, Al-Sultan MS, Saeed RIM. Pharmacists’ understanding and attitudes towards pharmaceutical care in Saudi Arabia. Saudi Pharm J. 2007;15(2):146–59.
30. Oparah AC, Eferakeya AE. Attitudes of Nigerian pharmacists towards pharmaceutical care. Pharm World Sci. 2005;27(3):208–14.
31. Berbatis CG, Sunderland VB, Joyce A, Bulsara M, Mills C. Enhanced pharmacy services, barriers and facilitators in Australia’s community pharmacies: Australia’s national pharmacy database project. Int J Pharm Pract. 2007;15(3):185–91.
32. Brazinha I, Fernandez-Llimos F. Barriers to the implementation of advanced clinical pharmacy services at Portuguese hospitals. Int J Clin Pharm. 2014;36(5):1031–8.
33. Uema SA, Vega EM, Armando PD, Fontana D. Barriers to pharmaceutical care in Argentina. Pharm World Sci. 2008;30(3):211–5.
34. Gastelurrutia MA, Faus MJ, Fernández-Llimós F. Providing patient care in community pharmacies in Spain. Ann Pharmacother. 2005;39(12):2105–10.